Neumora Therapeutics, Inc. (NMRA)
1.51
+0.01
(+0.67%)
USD |
NASDAQ |
Aug 26, 10:42
Neumora Therapeutics Total Assets (Quarterly) : 125.25M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 125.25M |
| March 31, 2026 | 153.88M |
| December 31, 2025 | 191.15M |
| September 30, 2025 | 177.83M |
| June 30, 2025 | 223.82M |
| March 31, 2025 | 256.75M |
| December 31, 2024 | 316.97M |
| September 30, 2024 | 352.54M |
| June 30, 2024 | 404.47M |
| Date | Value |
|---|---|
| March 31, 2024 | 450.21M |
| December 31, 2023 | 496.20M |
| September 30, 2023 | 544.75M |
| June 30, 2023 | 359.95M |
| March 31, 2023 | 392.09M |
| December 31, 2022 | 426.23M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 382.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Indivior Pharmaceuticals, Inc. | 1.233B |
| Liquidia Corp. | 521.92M |
| BioAge Labs, Inc. | 396.93M |
| LB Pharmaceuticals, Inc. | 361.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 80.73M |
| Shareholders Equity (Quarterly) | 44.52M |
| Debt to Equity Ratio | 1.196 |
| Current Ratio | 4.496 |
| Net Debt Paydown Yield | -3.29% |